Aurora Cannabis Inc

NASDAQ: ACB
$7.42
+$1.14 (+18.2%)
Closing price April 23, 2024
Aurora Cannabis Inc is a leading Canadian company specializing in the production, distribution, and sale of cannabis and its derivatives globally. With operations spanning across Canada, Europe, and other international markets, Aurora focuses on both medical and consumer cannabis products. Its diverse product lineup includes dried cannabis, oils, capsules, edibles, and CBD products, catering to a wide range of consumer preferences. Aurora also emphasizes recreational cannabis offerings and provides comprehensive patient counseling and outreach services. Its brand portfolio features names like Aurora Drift, San Rafael '71, and MedReleaf, showcasing a commitment to quality and consumer satisfaction.
24/7 Wall St. has tracked a group of companies that have simply refused to participate in the stock market upside.
Canadian cannabis grower and products maker Aurora Cannabis posted a much larger-than-expected full-year net loss after markets closed Tuesday.
Canada-based medical and recreational marijuana company Aurora Cannabis announced Monday that it has a new CEO and will take a substantial write-down on goodwill and other intangible assets.
A recent final ruling from the U.S. Drug Enforcement Administration has cast doubt on the legality of some non-psychoactive products derived from the hemp.
The coming elections may provide a huge tailwind for the cannabis industry in the United States. In a number of states, recreational marijuana will be on the ballot, which could be huge for three top...
Marijuana stocks have suffered a terrible beating in the past year or so. Here's a look at six former high-flyers and their prospects for a recovery.
Wednesday's top analyst upgrades and downgrades included Amazon.com, Aurora Cannabis, Comcast, Dick's Sporting Goods, Morgan Stanley, Nike, Nio, Plug Power, Snap and Walt Disney.
What does it say about long-term industry expectations when a leader in the cannabis field is laying off more employees and closing plants as a restructuring effort?
Aphria, an analyst favorite among pot stocks, rallies after market selloff Thursday.
Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability. In the United States, high state and...
There may be a new dawn for Aurora Cannabis as online sales rise, new retail outlets open, and Reliva deal offers access to U.S. market.
Aurora Cannabis closed its acquisition of Reliva ahead of schedule but poor results from Canopy Growth may have dinged pot stocks.
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased, and in one stock incredibly.
The euphoria that followed the announcement Wednesday that Aurora Cannabis is acquiring Reliva was subsiding Friday.
Friday's top analyst upgrades and downgrades included Agilent Technologies, Aurora Cannabis, Best Buy, Box, Marvell Technology, Nvidia, Palo Alto Networks, Roku, Splunk and TJX Companies.